Navigation Links
Neurobiological Technologies, Inc. Reports First Quarter Fiscal Year 2009 Financial Results
Date:11/6/2008

EMERYVILLE, Calif., Nov. 6 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (NTI(R)) (Nasdaq: NTII) today announced its financial results for the quarter ended September 30, 2008, the first quarter of the company's fiscal year ending June 30, 2009. Revenue for the three months ended September 30, 2008 was $3.6 million, compared to $3.9 million for the three months ended September 30, 2007. Operating expenses were $6.8 million for the first quarter of fiscal 2009 compared to $7.1 million for the same period in the prior year. Within the company's operating expenses, research and development was $5.5 million for each of the first quarters of fiscal 2009 and 2008, and general and administrative decreased to $1.3 million for the first quarter of fiscal 2009 compared to $1.7 million for the first quarter of fiscal 2008. The company's operating loss was $3.2 million for both periods. Net loss was $2.8 million for the three months ended September 30, 2008 compared to $0.9 million for the three months ended September 30, 2007. The increased net loss for the fiscal 2009 quarter was primarily due to a non-cash gain of $2.9 million recorded in the fiscal 2008 period as a result of fair-value accounting for a financial instrument. Net loss per share was $0.10 for the three months ended September 30, 2008 compared to $0.19 for the three months ended September 30, 2007. As of September 30, 2008, the company had $28.2 million in cash and short-term investments. The company also held $10.3 million in auction rate securities, which are classified as long-term investments.

"Our clinical team is making important progress on the development of Viprinex(TM) for acute ischemic stroke as we start our new fiscal year. This dedicated group is p
'/>"/>

SOURCE Neurobiological Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Neurobiological Technologies to Present at the Rodman & Renshaw 10th Annual Healthcare Conference in New York on November 10
2. Neurobiological Technologies Sets Date for First Quarter Financial Results
3. Neurobiological Technologies Reports Receipt of $2 Million Royalty Payment for Quarterly Sales of Memantine
4. Neurobiological Technologies to Present at the BIO Investor Forum in San Francisco on October 30, 2008
5. Neurobiological Technologies Announces Update Call on Viprinex (TM) Phase 3 Trial Program
6. Neurobiological Technologies, Inc. (Nasdaq: NTII) Q4/08 Review Issued by Scimitar Equity, LLC
7. Neurobiological Technologies Announces Dates for 2008 Fiscal Year End Financial Results Conference Call and Presentation at MCF Investor Summit
8. Neurobiological Technologies Reports Receipt of $2.1 Million Royalty Payment for Quarterly Sales of Memantine
9. Neurobiological Technologies CEO to Retire on December 31, 2008
10. Neurobiological Technologies Reports Third Quarter Financial Results
11. Neurobiological Technologies Sets Date for Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... SAN DIEGO and BETHESDA, Md. ... they are joining together with two institutes from the ... more reliable tools for bringing safer, more effective treatments ... with the National Center for Advancing Translational Sciences (NCATS) ...
(Date:1/14/2014)... WESTBOROUGH, Mass. , Jan. 14, 2014  RXi ... on discovering, developing and commercializing innovative therapies addressing ... announced that it received the Notice of Allowance ... on its unique self-delivering RNAi compounds (sd-rxRNA®), for ...
(Date:1/14/2014)... Cardiff, UK (PRWEB) January 13, 2014 ... leader with more than 20 years in the industry, ... and photonics . Hainsey will serve as the society’s ... have Dr. Hainsey join SPIE as our Technology Strategist, ...
(Date:1/14/2014)... 2014 Independent publisher Bitingduck Press, with ... Canada, has big ideas for 2014 in production and ... are to produce high-quality, low-cost, DRM-free ebooks and to ... , The first major development will be bookstore ...
Breaking Biology Technology:Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2Bitingduck Press Looks Forward to 2014 With Multimedia E-books 2
... KONG, Feb. 18 /PRNewswire-Asia/ -- Obio Pharmaceutical ... growth ticket to the,international pharmaceutical arena. With ... up by strong international investors including Yangtze,Ventures ... Tai Sang Land Properties,Limited, Yu Hwa Chinese ...
... 18 PharmaNet Development Group, Inc. (the "Company") (Nasdaq: ... development services to innovative pharmaceutical, biotechnology, generic drug and ... new office in Sao Paulo, Brazil to further enhance ... support in Latin America since 2002 with a network ...
... Feb. 18 Senesco Technologies, Inc. ("Senesco" or ... for the three months ended December 31, 2008. Net loss ... $1,624,341, or $0.09 per share, compared with a net loss ... period ended December 31, 2007. This increase in net ...
Cached Biology Technology:Obio Pharmaceutical Announces Product Growth Strategy 2Obio Pharmaceutical Announces Product Growth Strategy 3PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office 2PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office 3PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office 4PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office 5Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 2Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 3Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 4Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 5Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 6Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 7
(Date:4/17/2014)... Press journal Current Biology on April 17 ... lives. The Brazilian insects, which represent four distinct but ... the first example of an animal with sex-reversed genitalia. ... several different animals, Neotrogla is the only ... says Kazunori Yoshizawa from Hokkaido University in Japan. , ...
(Date:4/17/2014)... Pine forests are chock full of wild animals and ... populations of fungi are churning away in the soil, ... , Despite the vital role these fungi play in ... A Stanford-led team of scientists has generated a genetic ... North America. The work was published this week in ...
(Date:4/17/2014)... domestication derive from Charles Darwin, whose ideas in ... during the 19th century, a period when landowners ... is from Darwin that we inherit the ideas ... wild species and total human control over breeding ... this industrial setting has been applied too broadly ...
Breaking Biology News(10 mins):In sex-reversed cave insects, females have the penises 2Stanford biologists help solve fungal mysteries 2Stanford biologists help solve fungal mysteries 3The story of animal domestication retold 2The story of animal domestication retold 3The story of animal domestication retold 4
... L. Weber argues that China,s new title as the ... due to consumption of Chinese goods in the West. ... in the 2008 Olympic Games in Beijing, there is ... caused by smoke and smog from coal-fired plants that ...
... scientists will receive EMBO Installation Grants, assisting them to ... two scientists will receive funding in 2008 similar to ... European Molecular Biology Organization (EMBO) introduced the scheme in ... aim to strengthen science in selected member states of ...
... 2008) -- In a first, scientists from Weill Cornell ... the specifics of how brain cells process antidepressant drugs, ... in the development of more targeted medication therapies for ... area of addiction. Their breakthrough research, featured as ...
Cached Biology News:Carnegie Mellon Researcher says China's export trade impacts climate 2Scientists in Hungary and Portugal get research boost 2N.Y. research team discovers how antidepressants and cocaine interact with brain cell targets 2N.Y. research team discovers how antidepressants and cocaine interact with brain cell targets 3
... Direct In Situ Apoptosis Detection ... situ by the direct TUNEL ... tagged with a directly labeled ... fluorescence staining for 40 samples ...
... Kit is a two color staining ... cellular DNA to detect apoptotic cells by ... instructions and reagents required for measuring apoptosis ... cells for assessing reagent performance; washing, reaction, ...
The stirbar is used in the buffer tank of the Trans-Blot Plus cell to maintain uniform conductivity and temperature during electrophoretic transfer. Dimensions are 3.5 x 0.5 in....
... is the latest entry in the Biomek line. ... and increased robustness, it can meet the needs ... configured with either one or two pipetting pods. ... sets the standard for flexible laboratory solutions to ...
Biology Products: